The Role Of Capsid Protein Nucleolar Localisation In Chikungunya Virus: Implications For Vaccine Development
Funder
National Health and Medical Research Council
Funding Amount
$520,520.00
Summary
Chikungunya virus (CHIKV) is a globally widespread mosquito-borne alphavirus capable of causing considerable human morbidity and mortality. With no CHIKV vaccine or antiviral available this proposal aims to develop a live attenuated CHIKV vaccine, rationally designed by investigating the host cell nucleolar trafficking of CHIKV capsid protein. This vaccine has the potential to provide cross-protection against additional arthritogenic alphaviruses endemic to Australia such as Ross River virus.
Mosquito-borne alphaviruses such as Ross River and chikungunya viruses cause widespread epidemics and exert extreme pressure on the public health systems of affected regions. Alphaviruses spreads to joints and triggers a severe disease in those affected. There are no effective treatments or vaccines. The project will investigate virus-host interaction at the bite site. The outcome will be new knowledge to treat infection at the mosquito bite site to prevent joint disease.
Novel Insights Into The Pathobiology Of Alphavirus Infections
Funder
National Health and Medical Research Council
Funding Amount
$827,660.00
Summary
Infections with mosquito-borne viruses are increasing at an alarming rate worldwide. Ross River virus is endemic in parts of Australia, PNG and Pacific islands, while chikungunya virus is distributed globally and causes recurrent pandemics that involve millions of people. These viruses cause severe musculoskeletal disease for several months after infection. This project aims to establish how these viruses interact with the human host to cause disease and may provide a basis for new treatments.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE170100093
Funder
Australian Research Council
Funding Amount
$510,000.00
Summary
High-throughput technology targeting antimicrobial resistance in animals. This project aims to establish reference laboratories as biobanks for resistant isolate collections from veterinary diagnostic laboratories / surveillance programmes and a national research network to mitigate antimicrobial resistance in animals. Antimicrobial resistance in zoonotic/foodborne pathogens and livestock commensals is a global issue. This project will use mass-spectroscopy biotypers, information management soft ....High-throughput technology targeting antimicrobial resistance in animals. This project aims to establish reference laboratories as biobanks for resistant isolate collections from veterinary diagnostic laboratories / surveillance programmes and a national research network to mitigate antimicrobial resistance in animals. Antimicrobial resistance in zoonotic/foodborne pathogens and livestock commensals is a global issue. This project will use mass-spectroscopy biotypers, information management software, robotic liquid handling and a research dairy to develop high-throughput screening technologies to rapidly determine major animal species’ resistance status, and research anti-infectives and vaccines for livestock diseases. This will improve the health and production of Australian livestock, leading to greater market access for high quality products.Read moreRead less